217 related articles for article (PubMed ID: 8257680)
21. NMR evidence for a short, strong hydrogen bond at the active site of a cholinesterase.
Viragh C; Harris TK; Reddy PM; Massiah MA; Mildvan AS; Kovach IM
Biochemistry; 2000 Dec; 39(51):16200-5. PubMed ID: 11123949
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and 31P chemical shift identification of tripeptide active site models that represent human serum acetylcholinesterase covalently modified at serine by certain organophosphates.
Thompson CM; Suarez AI; Rodriguez OP
Chem Res Toxicol; 1996 Dec; 9(8):1325-32. PubMed ID: 8951236
[TBL] [Abstract][Full Text] [Related]
23. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
24. Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.
Epstein TM; Samanta U; Kirby SD; Cerasoli DM; Bahnson BJ
Biochemistry; 2009 Apr; 48(15):3425-35. PubMed ID: 19271773
[TBL] [Abstract][Full Text] [Related]
25. Key active site residues in the inhibition of acetylcholinesterases by soman.
Qian N; Kovach IM
FEBS Lett; 1993 Dec; 336(2):263-6. PubMed ID: 8262242
[TBL] [Abstract][Full Text] [Related]
26. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
27. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.
Millard CB; Kryger G; Ordentlich A; Greenblatt HM; Harel M; Raves ML; Segall Y; Barak D; Shafferman A; Silman I; Sussman JL
Biochemistry; 1999 Jun; 38(22):7032-9. PubMed ID: 10353814
[TBL] [Abstract][Full Text] [Related]
28. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.
Ekström F; Akfur C; Tunemalm AK; Lundberg S
Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582
[TBL] [Abstract][Full Text] [Related]
29. Stereospecific reactivation of human brain and erythrocyte acetylcholinesterase inhibited by 1,2,2-trimethylpropyl methylphosphonofluoridate (soman).
de Jong LP; Kossen SP
Biochim Biophys Acta; 1985 Aug; 830(3):345-8. PubMed ID: 4027255
[TBL] [Abstract][Full Text] [Related]
30. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
31. A step toward the reactivation of aged cholinesterases--crystal structure of ligands binding to aged human butyrylcholinesterase.
Wandhammer M; de Koning M; van Grol M; Loiodice M; Saurel L; Noort D; Goeldner M; Nachon F
Chem Biol Interact; 2013 Mar; 203(1):19-23. PubMed ID: 22922115
[TBL] [Abstract][Full Text] [Related]
32. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
[TBL] [Abstract][Full Text] [Related]
33. Evidence that the conformational stability of 'aged' organophosphate-inhibited cholinesterase is altered.
Masson P; Goasdoue JL
Biochim Biophys Acta; 1986 Feb; 869(3):304-13. PubMed ID: 3947640
[TBL] [Abstract][Full Text] [Related]
34. Structural and hydration changes in the active site gorge of phosporhylated butyrylcholinesterase accompanying the aging process.
Masson P; Fortier PL; Albaret C; Cléry C; Guerra P; Lockridge O
Chem Biol Interact; 1999 May; 119-120():17-27. PubMed ID: 10421435
[TBL] [Abstract][Full Text] [Related]
35. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP).
Little JS; Broomfield CA; Fox-Talbot MK; Boucher LJ; MacIver B; Lenz DE
Biochem Pharmacol; 1989 Jan; 38(1):23-9. PubMed ID: 2910306
[TBL] [Abstract][Full Text] [Related]
36. Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel.
Hanke DW; Overton MA
J Toxicol Environ Health; 1991 Sep; 34(1):141-56. PubMed ID: 1890690
[TBL] [Abstract][Full Text] [Related]
37. Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman.
Benschop HP; Konings CA; Van Genderen J; De Jong LP
Toxicol Appl Pharmacol; 1984 Jan; 72(1):61-74. PubMed ID: 6710485
[TBL] [Abstract][Full Text] [Related]
38. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
[TBL] [Abstract][Full Text] [Related]
39. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
